Long-Term Follow-Up of Focused Ultrasound Thalamotomy for Parkinson's Tremor
Tracks long-term safety and results of a focused ultrasound brain procedure for severe Parkinson's tremor.
Plain-language title generated from the registry record
Registry title: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
Key facts
- Where
- Dundee, United KingdomSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 99 years old?
Source: NCT04991831, who can take part
Where in United Kingdom
- University of DundeeDundee, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- InSightec
- Trial code
- NCT04991831
- Record updated
- 20 March 2026
- Original description
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.Read full original descriptionShow less
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
Inclusion: Men and women, age 30 years and older; Subject undergoing an Exablate procedure for their planned TDPD treatment; per local institution standard of care; Subject is willing to cooperate with the Registry requirements including compliance with the regimen and completion of all study visits; Subject has signed and received a copy of the approved informed consent form.
Exclusion: Subject does not agree to participate or is unlikely to participate for the entirety of the study.